As Congress Eyes Medical Innovation, FDA, NIH Stakeholders Push Consortia

FDA and NIH, as well as academic and industry stakeholders, are pressing Congress to provide renewable funding to support research consortia developing new tools that can spur medical innovation. While the House Energy and Commerce Committee's 21st Century Cures Initiative has examined areas where FDA and CMS policies can be revamped, industry and academic researchers last week also called for lawmakers to prioritize funding of consortia that often involve federal agencies but have unstable funding. Consortia are neutral environments where...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.